Circulating markers of inflammation and atherosclerosis.
about
Is Ramadan fasting related to health outcomes? A review on the related evidencePolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenInsight in modulation of inflammation in response to diclofenac intervention: a human intervention studyRole of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker ratsMediterranean diet, dietary polyphenols and low grade inflammation: results from the MOLI-SANI study.A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study.Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages.The relation between neutrophil-to-lymphocyte ratio and coronary chronic total occlusions.Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways.Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failureAssociation of SELE genotypes/haplotypes with sE-selectin levels in Taiwanese individuals: interactive effect of MMP9 level.Association of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertensionIncreased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.Trait anger, cynical hostility and inflammation in Latinas: variations by anger type?Exposure to welding fumes is associated with acute systemic inflammatory responses.Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation.The association between chronic stress type and C-reactive protein in the multi-ethnic study of atherosclerosis: does gender make a difference?Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy.Pro-inflammatory effect of fibrinogen on vascular smooth muscle cells by regulating the expression of PPARα, PPARγ and MMP-9Large artery stiffness and inflammation.Circulatory syndrome: an evolution of the metabolic syndrome concept!Anti-inflammatory effect of supercritical extract and its constituents from Ishige okamurae.Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic SyndromeProtective effects of angiotensin II interruption: evidence for antiinflammatory actions.Inflammatory mechanisms in the regulation of insulin resistance.Immunomodulatory Effects of Dioscoreae Rhizome Against Inflammation through Suppressed Production of Cytokines Via Inhibition of the NF-κB Pathway.Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic Peptide.Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: a pilot study.Relationship between plasma fibrinogen levels and pulmonary function in the japanese population: the Takahata study.Early time-dependent dynamic changes of TBET and GATA3 mRNA expressions in patients with acute coronary syndromeTargets for immunomodulation in cardiovascular disease--where are we now?Imaging and molecular biomarkers of vulnerable atheromatous plaques.Atherosclerosis and interferon-γ: new insights and therapeutic targetsInflammation, heart disease, and depression.Inflammation-induced foam cell formation in chronic inflammatory disease.Anti-inflammatory potential of newly synthesized 4-[(butylsulfinyl)methyl]-1,2-benzenediol in lipopolysaccharide-stimulated BV2 microglia.Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease.
P2860
Q26996704-66BCF65D-A0E8-4A3C-B48C-D99C0C48E818Q27021307-2F0577CF-899A-4478-A200-ABDFB8412212Q28394193-F3581CF2-62C6-430D-AD2A-DE827CFF0F19Q28571720-C4E94F09-108B-42EF-9E15-E76F908949F9Q30251846-2F529FB2-AFE5-48C2-B074-0D53FEFFB59CQ33573546-EA278C11-8BA0-4381-BFC2-4C5F47463594Q34157980-CDF54F91-8AD9-49D0-A473-AECB66901275Q34333080-2B619CBD-E47E-4260-BA4E-B96CAE58801CQ34386876-59DA4DDE-E981-4992-A8A6-324F586E437BQ34407902-8C4C45DC-A041-4530-8785-E630D2B9CF72Q34494426-D032B726-AA3D-4761-9D31-9A57BFAD7BB0Q34564055-2D866984-73D7-4DD6-8228-7FAA7F3C29C0Q35061053-1A3267EF-70E4-443F-BE57-526465C2EF23Q35112940-C6719C74-83FA-4397-9F57-624502A00A42Q35502844-C774841D-4647-4AFA-A02F-FA5CDB3D1581Q35624562-12340026-F606-441B-8EFF-6775F14E5AFEQ35714112-5743EA25-9882-4DC0-84FF-EF3717FC7FDDQ35802575-5C8C2224-4B18-424E-AFFA-00F20B12FE4DQ35803130-D316CB2D-FE54-40E4-90F4-76313F606535Q36007909-8D7A264A-1C0F-487B-BCB4-E01B6D635B76Q36087928-5A4BADC2-BC83-455C-9A7C-4062BE28E389Q36185105-31160E30-6FE8-419E-BDBD-1DC048F97548Q36204524-836DDAAB-1E81-480E-BA33-79F49A1F2F78Q36257966-A751ABC7-B4BB-4A01-9DC6-8ACACF6A8D0FQ36409227-CADB7784-C7D7-42AF-AC16-34B07901C001Q36431005-E6383005-281D-4EEC-9233-7114860C6BB3Q36508782-D8C613F7-CEE7-4024-89EE-A84C06987C12Q36680316-07176356-180A-4B32-AD62-0046E608D83DQ36760107-7D3C9C2D-CB2A-4F74-B5F1-E3268921CFF7Q37091275-547124DE-1D6A-4904-BBBD-7E6F362A832AQ37145645-A58ADF9E-4EA2-4C95-BD72-2D69BC0EF17FQ37176968-C1E47D46-2EE8-4711-B8CB-A6A6CC593827Q37260336-D31714BC-5228-4928-80D3-92B8254D489BQ37608525-0FF6BC02-99DE-4E0C-BEB8-138869969CD6Q37755125-7AC2C6DE-D2A8-4032-BBCC-028A6C5D3772Q38126725-4F75FF18-53CE-47F3-873A-E55923843FD1Q38131387-C489770D-C77F-4C68-BD15-2E7A9357537EQ38370895-ED35FA17-F621-4CF8-9175-BBFFB0102D77Q38947251-BA4FFABD-043E-4DE5-8F0E-46B7E0BF1428Q39004263-7BFD9721-9E8E-40CB-A6FB-97E38B713CF6
P2860
Circulating markers of inflammation and atherosclerosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Circulating markers of inflammation and atherosclerosis.
@ast
Circulating markers of inflammation and atherosclerosis.
@en
type
label
Circulating markers of inflammation and atherosclerosis.
@ast
Circulating markers of inflammation and atherosclerosis.
@en
prefLabel
Circulating markers of inflammation and atherosclerosis.
@ast
Circulating markers of inflammation and atherosclerosis.
@en
P1433
P1476
Circulating markers of inflammation and atherosclerosis.
@en
P2093
P304
P356
10.1016/S0021-9150(03)00012-1
P577
2003-08-01T00:00:00Z